NEW YORK--(BUSINESS WIRE)--The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Myriad Genetics, Inc. (“Myriad Genetics” or the “Company”) (NASDAQGS:MYGN) violated federal securities laws.
Click here to learn about the case: http://docs.wongesq.com/MYGN-Info-Request-Form-1883. There is no cost or obligation to you.
On March 12, 2018, Myriad Genetics filed an 8-K with the U.S. Securities and Exchange Commission disclosing the receipt of a subpoena from the Department of Health and Human Services concerning “an investigation into possible false or otherwise improper claims submitted for payment under Medicare and Medicaid.” The subpoena requests documents related to Myriad Genetic’s “billing to government-funded healthcare programs for the Company’s hereditary cancer testing” from 2014 through the receipt of the subpoena.
To learn more about the investigation of Myriad Genetics contact Vincent Wong, Esq. either via email email@example.com, by telephone at 212.425.1140, or visit http://docs.wongesq.com/MYGN-Info-Request-Form-1883.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.